Viewing Study NCT00512902



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00512902
Status: COMPLETED
Last Update Posted: 2014-10-27
First Post: 2007-08-06

Brief Title: A Study Using The Experimental Drug Called Imatinib Gleevec in Subjects With Systemic Sclerosis
Sponsor: University of California Los Angeles
Organization: University of California Los Angeles

Study Overview

Official Title: Pilot Study to Examine The Use of Imatinib Gleevec For The Treatment of Active Alveolitis in Systemic Sclerosis
Status: COMPLETED
Status Verified Date: 2014-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess the safety and tolerability of imatinib gleevec in subjects who have systemic sclerosis Imatinib has been approved by the FDA for the treatment of newly diagnosed adult patients with CML newly diagnosed adult patients and for the treatment of patients with an accelerated phase Imatinib is also approved for the treatment of patients with a certain type of gastrointestinal cancer called stromal tumors but it has not been approved to treat systemic sclerosis Imatinib works by interfering with an enzyme called tyrosine phosphatase resulting in suppression of the immune system It als interferes with a protein called platelet derived growth factor receptor PDGFr that has been linked to increased fibrosis
Detailed Description: Systemic sclerosis is a rare progressive disease that leads to hardening and tightening of the skin and connective tissues It usually begins with a few dry patches of skin on the hands or face that begin getting thicker and harder These patches then spread to other areas of the skin In some cases systemic sclerosis also affects the blood vessels an internal organs Systemic sclerosis is one of a group of arthritic conditions called connective tissue disorders a persons antibodies are directed against their own tissues

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None